Anthropic’s Claude has independently designed protein binders aimed at a deadly scorpion neurotoxin, according to Techub, citing The Decoder. The report said more than 318,000 designs were generated, with 211 of them selected for laboratory testing. Of those, 17 met the required benchmark. The two strongest candidates were found to bind very tightly to the Cn2 toxin from a Mexican scorpion. The report did not say the work had already produced a usable treatment. It added that whether these binders can actually function as an antivenom still needs to be verified. The result points to a lab-tested screening outcome rather than a confirmed medical application at this stage.
Anthropic’s Claude independently designed protein binders targeting a deadly scorpion neurotoxin, Techub reported, citing The Decoder.
Out of more than 318,000 designs, 211 were tested in the lab, and 17 met the benchmark. The two strongest binders were able to bind very tightly to the Cn2 toxin from a Mexican scorpion.
Whether they can actually work as an antivenom still remains to be verified.
This article was originally published by Bit.Fan. For more cryptocurrency news and market insights, visit www.bit.fan. Disclaimer:
The market information, project data, and third-party content displayed on this platform are for industry information sharing only and do not constitute any form of investment advice or return commitment.
Cryptocurrency trading carries high risks. Users should fully assess their risk tolerance and make independent decisions. All profits, losses, and legal responsibilities are borne by the users themselves.